For the LT candidate, they recommended that it is better to monitor the progress of the T1 tumor without BT, but once the AFP is elevated to ≥500 ng/mL or the tumor is growing in a short period of time, locoregional therapy should be given as soon as possible. This evidence concerns the gene AFP and neoplasm.